Editors' Pick Leisure-Time Physical Activity and the Risk of Incident Dementia: The Mayo Clinic Study of Aging. Krell-Roesch J, Feder NT, Roberts RO, Mielke MM, Christianson TJ, Knopman DS, Petersen RC, Geda YE J Alzheimers Dis. 2018; 63(1):149-155. PMID: 29614667. Abstract Editors' Pick Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease. Teunissen CE, Chiu M-J, Yang C-C, Yang S-Y, Scheltens P, Zetterberg H, Blennow K J Alzheimers Dis. 2018; 62(4):1857-1863. PMID: 29614646. Abstract Editors' Pick Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET. Stonnington CM, Chen Y, Savage CR, Lee W, Iii RJBauer, Sharieff S, Thiyyagura P, Alexander GE, Caselli RJ, Locke DEC, et al. J Alzheimers Dis. 2018 Apr 04. PMID: 29630550. Abstract Editors' Pick Insulin Resistance and Future Cognitive Performance and Cognitive Decline in Elderly Patients with Cardiovascular Disease. Lutski M, Weinstein G, Goldbourt U, Tanne D J Alzheimers Dis. 2017; 57(2):633-643. PMID: 28304291. Abstract Editors' Pick Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. Cummings J, Ritter A, Zhong K J Alzheimers Dis. 2018 Mar 16. PMID: 29562511. Abstract Editors' Pick Underlying Biological Processes in Mild Cognitive Impairment: Amyloidosis Versus Neurodegeneration. Santana I, Baldeiras I, Santiago B, Duro D, Freitas S, Pereira MTábuas, Almeida MRosário, Oliveira CResende J Alzheimers Dis. 2018 Mar 16. PMID: 29562515. Abstract Editors' Pick Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging. Dorninger F, Moser AB, Kou J, Wiesinger C, Forss-Petter S, Gleiss A, Hinterberger M, Jungwirth S, Fischer P, Berger J J Alzheimers Dis. 2018; 62(2):841-854. PMID: 29480199. Abstract Editors' Pick Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment. Wang D, Schultz T, Novak GP, Baker S, Bennett DA, Narayan VA J Alzheimers Dis. 2018; 62(2):855-865. PMID: 29480187. Abstract Editors' Pick Generation of a New Tau Knockout (tauΔex1) Line Using CRISPR/Cas9 Genome Editing in Mice. Tan DCS, Yao S, Ittner A, Bertz J, Ke YD, Ittner LM, Delerue F J Alzheimers Dis. 2018; 62(2):571-578. PMID: 29480201. Abstract Editors' Pick Evolvability of Amyloidogenic Proteins in Human Brain. Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E J Alzheimers Dis. 2018; 62(1):73-83. PMID: 29439348. Abstract Pages123456789…next ›last »
Editors' Pick Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease. Teunissen CE, Chiu M-J, Yang C-C, Yang S-Y, Scheltens P, Zetterberg H, Blennow K J Alzheimers Dis. 2018; 62(4):1857-1863. PMID: 29614646. Abstract Editors' Pick Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET. Stonnington CM, Chen Y, Savage CR, Lee W, Iii RJBauer, Sharieff S, Thiyyagura P, Alexander GE, Caselli RJ, Locke DEC, et al. J Alzheimers Dis. 2018 Apr 04. PMID: 29630550. Abstract Editors' Pick Insulin Resistance and Future Cognitive Performance and Cognitive Decline in Elderly Patients with Cardiovascular Disease. Lutski M, Weinstein G, Goldbourt U, Tanne D J Alzheimers Dis. 2017; 57(2):633-643. PMID: 28304291. Abstract Editors' Pick Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. Cummings J, Ritter A, Zhong K J Alzheimers Dis. 2018 Mar 16. PMID: 29562511. Abstract Editors' Pick Underlying Biological Processes in Mild Cognitive Impairment: Amyloidosis Versus Neurodegeneration. Santana I, Baldeiras I, Santiago B, Duro D, Freitas S, Pereira MTábuas, Almeida MRosário, Oliveira CResende J Alzheimers Dis. 2018 Mar 16. PMID: 29562515. Abstract Editors' Pick Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging. Dorninger F, Moser AB, Kou J, Wiesinger C, Forss-Petter S, Gleiss A, Hinterberger M, Jungwirth S, Fischer P, Berger J J Alzheimers Dis. 2018; 62(2):841-854. PMID: 29480199. Abstract Editors' Pick Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment. Wang D, Schultz T, Novak GP, Baker S, Bennett DA, Narayan VA J Alzheimers Dis. 2018; 62(2):855-865. PMID: 29480187. Abstract Editors' Pick Generation of a New Tau Knockout (tauΔex1) Line Using CRISPR/Cas9 Genome Editing in Mice. Tan DCS, Yao S, Ittner A, Bertz J, Ke YD, Ittner LM, Delerue F J Alzheimers Dis. 2018; 62(2):571-578. PMID: 29480201. Abstract Editors' Pick Evolvability of Amyloidogenic Proteins in Human Brain. Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E J Alzheimers Dis. 2018; 62(1):73-83. PMID: 29439348. Abstract Pages123456789…next ›last »
Editors' Pick Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET. Stonnington CM, Chen Y, Savage CR, Lee W, Iii RJBauer, Sharieff S, Thiyyagura P, Alexander GE, Caselli RJ, Locke DEC, et al. J Alzheimers Dis. 2018 Apr 04. PMID: 29630550. Abstract Editors' Pick Insulin Resistance and Future Cognitive Performance and Cognitive Decline in Elderly Patients with Cardiovascular Disease. Lutski M, Weinstein G, Goldbourt U, Tanne D J Alzheimers Dis. 2017; 57(2):633-643. PMID: 28304291. Abstract Editors' Pick Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. Cummings J, Ritter A, Zhong K J Alzheimers Dis. 2018 Mar 16. PMID: 29562511. Abstract Editors' Pick Underlying Biological Processes in Mild Cognitive Impairment: Amyloidosis Versus Neurodegeneration. Santana I, Baldeiras I, Santiago B, Duro D, Freitas S, Pereira MTábuas, Almeida MRosário, Oliveira CResende J Alzheimers Dis. 2018 Mar 16. PMID: 29562515. Abstract Editors' Pick Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging. Dorninger F, Moser AB, Kou J, Wiesinger C, Forss-Petter S, Gleiss A, Hinterberger M, Jungwirth S, Fischer P, Berger J J Alzheimers Dis. 2018; 62(2):841-854. PMID: 29480199. Abstract Editors' Pick Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment. Wang D, Schultz T, Novak GP, Baker S, Bennett DA, Narayan VA J Alzheimers Dis. 2018; 62(2):855-865. PMID: 29480187. Abstract Editors' Pick Generation of a New Tau Knockout (tauΔex1) Line Using CRISPR/Cas9 Genome Editing in Mice. Tan DCS, Yao S, Ittner A, Bertz J, Ke YD, Ittner LM, Delerue F J Alzheimers Dis. 2018; 62(2):571-578. PMID: 29480201. Abstract Editors' Pick Evolvability of Amyloidogenic Proteins in Human Brain. Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E J Alzheimers Dis. 2018; 62(1):73-83. PMID: 29439348. Abstract Pages123456789…next ›last »
Editors' Pick Insulin Resistance and Future Cognitive Performance and Cognitive Decline in Elderly Patients with Cardiovascular Disease. Lutski M, Weinstein G, Goldbourt U, Tanne D J Alzheimers Dis. 2017; 57(2):633-643. PMID: 28304291. Abstract Editors' Pick Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. Cummings J, Ritter A, Zhong K J Alzheimers Dis. 2018 Mar 16. PMID: 29562511. Abstract Editors' Pick Underlying Biological Processes in Mild Cognitive Impairment: Amyloidosis Versus Neurodegeneration. Santana I, Baldeiras I, Santiago B, Duro D, Freitas S, Pereira MTábuas, Almeida MRosário, Oliveira CResende J Alzheimers Dis. 2018 Mar 16. PMID: 29562515. Abstract Editors' Pick Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging. Dorninger F, Moser AB, Kou J, Wiesinger C, Forss-Petter S, Gleiss A, Hinterberger M, Jungwirth S, Fischer P, Berger J J Alzheimers Dis. 2018; 62(2):841-854. PMID: 29480199. Abstract Editors' Pick Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment. Wang D, Schultz T, Novak GP, Baker S, Bennett DA, Narayan VA J Alzheimers Dis. 2018; 62(2):855-865. PMID: 29480187. Abstract Editors' Pick Generation of a New Tau Knockout (tauΔex1) Line Using CRISPR/Cas9 Genome Editing in Mice. Tan DCS, Yao S, Ittner A, Bertz J, Ke YD, Ittner LM, Delerue F J Alzheimers Dis. 2018; 62(2):571-578. PMID: 29480201. Abstract Editors' Pick Evolvability of Amyloidogenic Proteins in Human Brain. Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E J Alzheimers Dis. 2018; 62(1):73-83. PMID: 29439348. Abstract Pages123456789…next ›last »
Editors' Pick Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. Cummings J, Ritter A, Zhong K J Alzheimers Dis. 2018 Mar 16. PMID: 29562511. Abstract Editors' Pick Underlying Biological Processes in Mild Cognitive Impairment: Amyloidosis Versus Neurodegeneration. Santana I, Baldeiras I, Santiago B, Duro D, Freitas S, Pereira MTábuas, Almeida MRosário, Oliveira CResende J Alzheimers Dis. 2018 Mar 16. PMID: 29562515. Abstract Editors' Pick Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging. Dorninger F, Moser AB, Kou J, Wiesinger C, Forss-Petter S, Gleiss A, Hinterberger M, Jungwirth S, Fischer P, Berger J J Alzheimers Dis. 2018; 62(2):841-854. PMID: 29480199. Abstract Editors' Pick Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment. Wang D, Schultz T, Novak GP, Baker S, Bennett DA, Narayan VA J Alzheimers Dis. 2018; 62(2):855-865. PMID: 29480187. Abstract Editors' Pick Generation of a New Tau Knockout (tauΔex1) Line Using CRISPR/Cas9 Genome Editing in Mice. Tan DCS, Yao S, Ittner A, Bertz J, Ke YD, Ittner LM, Delerue F J Alzheimers Dis. 2018; 62(2):571-578. PMID: 29480201. Abstract Editors' Pick Evolvability of Amyloidogenic Proteins in Human Brain. Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E J Alzheimers Dis. 2018; 62(1):73-83. PMID: 29439348. Abstract Pages123456789…next ›last »
Editors' Pick Underlying Biological Processes in Mild Cognitive Impairment: Amyloidosis Versus Neurodegeneration. Santana I, Baldeiras I, Santiago B, Duro D, Freitas S, Pereira MTábuas, Almeida MRosário, Oliveira CResende J Alzheimers Dis. 2018 Mar 16. PMID: 29562515. Abstract Editors' Pick Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging. Dorninger F, Moser AB, Kou J, Wiesinger C, Forss-Petter S, Gleiss A, Hinterberger M, Jungwirth S, Fischer P, Berger J J Alzheimers Dis. 2018; 62(2):841-854. PMID: 29480199. Abstract Editors' Pick Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment. Wang D, Schultz T, Novak GP, Baker S, Bennett DA, Narayan VA J Alzheimers Dis. 2018; 62(2):855-865. PMID: 29480187. Abstract Editors' Pick Generation of a New Tau Knockout (tauΔex1) Line Using CRISPR/Cas9 Genome Editing in Mice. Tan DCS, Yao S, Ittner A, Bertz J, Ke YD, Ittner LM, Delerue F J Alzheimers Dis. 2018; 62(2):571-578. PMID: 29480201. Abstract Editors' Pick Evolvability of Amyloidogenic Proteins in Human Brain. Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E J Alzheimers Dis. 2018; 62(1):73-83. PMID: 29439348. Abstract Pages123456789…next ›last »
Editors' Pick Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging. Dorninger F, Moser AB, Kou J, Wiesinger C, Forss-Petter S, Gleiss A, Hinterberger M, Jungwirth S, Fischer P, Berger J J Alzheimers Dis. 2018; 62(2):841-854. PMID: 29480199. Abstract Editors' Pick Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment. Wang D, Schultz T, Novak GP, Baker S, Bennett DA, Narayan VA J Alzheimers Dis. 2018; 62(2):855-865. PMID: 29480187. Abstract Editors' Pick Generation of a New Tau Knockout (tauΔex1) Line Using CRISPR/Cas9 Genome Editing in Mice. Tan DCS, Yao S, Ittner A, Bertz J, Ke YD, Ittner LM, Delerue F J Alzheimers Dis. 2018; 62(2):571-578. PMID: 29480201. Abstract Editors' Pick Evolvability of Amyloidogenic Proteins in Human Brain. Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E J Alzheimers Dis. 2018; 62(1):73-83. PMID: 29439348. Abstract Pages123456789…next ›last »
Editors' Pick Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment. Wang D, Schultz T, Novak GP, Baker S, Bennett DA, Narayan VA J Alzheimers Dis. 2018; 62(2):855-865. PMID: 29480187. Abstract Editors' Pick Generation of a New Tau Knockout (tauΔex1) Line Using CRISPR/Cas9 Genome Editing in Mice. Tan DCS, Yao S, Ittner A, Bertz J, Ke YD, Ittner LM, Delerue F J Alzheimers Dis. 2018; 62(2):571-578. PMID: 29480201. Abstract Editors' Pick Evolvability of Amyloidogenic Proteins in Human Brain. Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E J Alzheimers Dis. 2018; 62(1):73-83. PMID: 29439348. Abstract Pages123456789…next ›last »
Editors' Pick Generation of a New Tau Knockout (tauΔex1) Line Using CRISPR/Cas9 Genome Editing in Mice. Tan DCS, Yao S, Ittner A, Bertz J, Ke YD, Ittner LM, Delerue F J Alzheimers Dis. 2018; 62(2):571-578. PMID: 29480201. Abstract Editors' Pick Evolvability of Amyloidogenic Proteins in Human Brain. Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E J Alzheimers Dis. 2018; 62(1):73-83. PMID: 29439348. Abstract Pages123456789…next ›last »
Editors' Pick Evolvability of Amyloidogenic Proteins in Human Brain. Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E J Alzheimers Dis. 2018; 62(1):73-83. PMID: 29439348. Abstract Pages123456789…next ›last »
